EX1U-9 ACCT LTR 2 glst_ex99z1.htm AUDITOR LETTER

 

EXHIBIT 99.1

 

 

October 7, 2022

 

 

 

AD Office of Life Sciences

Securities and Exchange Commission

100 F St., NE, Mail Stop 4561

Washington, DC 20549-4561

 

 

To the Assistant Director Office:

 

We have received a copy of, and are in agreement with, the statements being made by GelStat Corp. in Item 4 of its Form 1-U dated October 5, 2022, captioned “Changes in Issuer’s Certifying Accountant”.

 

  Very truly yours,
   
 

 

 

 

 

 

56 Rockford Road, Wilmington, DE 19806-1004 | Phone: 302-652-4783

ciroadamscpa.com